ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 547 filers reported holding ASTRAZENECA PLC in Q3 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,365,802 | +23.3% | 55,979 | +7.1% | 0.16% | +34.1% |
Q1 2024 | $3,541,564 | +11.2% | 52,274 | +10.5% | 0.12% | +7.9% |
Q4 2023 | $3,184,914 | -9.8% | 47,289 | -9.3% | 0.11% | -13.0% |
Q3 2023 | $3,529,499 | -8.4% | 52,119 | -3.2% | 0.13% | +6.5% |
Q2 2023 | $3,854,331 | +0.8% | 53,854 | -2.3% | 0.12% | +0.8% |
Q1 2023 | $3,825,185 | -2.1% | 55,110 | -4.4% | 0.12% | -5.4% |
Q4 2022 | $3,908,128 | +20.8% | 57,642 | -2.3% | 0.13% | +16.2% |
Q3 2022 | $3,234,000 | -12.0% | 58,970 | +6.0% | 0.11% | -0.9% |
Q2 2022 | $3,675,000 | +53.3% | 55,616 | +53.9% | 0.11% | +138.3% |
Q1 2022 | $2,398,000 | +14.8% | 36,142 | +0.8% | 0.05% | +17.5% |
Q4 2021 | $2,088,000 | -11.7% | 35,850 | -9.0% | 0.04% | -18.4% |
Q3 2021 | $2,366,000 | -1.8% | 39,399 | -2.0% | 0.05% | +4.3% |
Q2 2021 | $2,409,000 | +21.5% | 40,222 | +0.8% | 0.05% | +42.4% |
Q1 2021 | $1,983,000 | -30.0% | 39,883 | -29.6% | 0.03% | -50.0% |
Q4 2020 | $2,831,000 | -8.9% | 56,635 | -0.1% | 0.07% | -19.5% |
Q3 2020 | $3,107,000 | +3.8% | 56,705 | +0.2% | 0.08% | +6.5% |
Q2 2020 | $2,992,000 | +17.7% | 56,574 | -0.6% | 0.08% | +1.3% |
Q1 2020 | $2,542,000 | +46.6% | 56,914 | +63.7% | 0.08% | +111.1% |
Q4 2019 | $1,734,000 | -56.2% | 34,775 | -60.8% | 0.04% | -54.4% |
Q3 2019 | $3,958,000 | +35.5% | 88,796 | +25.5% | 0.08% | +38.6% |
Q2 2019 | $2,921,000 | +8.1% | 70,769 | +5.9% | 0.06% | +14.0% |
Q1 2019 | $2,702,000 | -44.4% | 66,831 | -47.8% | 0.05% | -51.0% |
Q4 2018 | $4,861,000 | -13.2% | 127,984 | -9.5% | 0.10% | +8.5% |
Q3 2018 | $5,598,000 | +11.0% | 141,465 | -1.5% | 0.09% | +10.6% |
Q2 2018 | $5,043,000 | -8.0% | 143,632 | -8.3% | 0.08% | -10.5% |
Q1 2018 | $5,479,000 | -0.9% | 156,688 | -1.6% | 0.10% | +17.3% |
Q4 2017 | $5,526,000 | +0.2% | 159,256 | -2.2% | 0.08% | -1.2% |
Q3 2017 | $5,515,000 | -2.5% | 162,778 | -1.9% | 0.08% | -6.8% |
Q2 2017 | $5,658,000 | +7.4% | 165,978 | -1.9% | 0.09% | +10.0% |
Q1 2017 | $5,270,000 | +8.5% | 169,238 | -4.8% | 0.08% | +11.1% |
Q4 2016 | $4,857,000 | -22.3% | 177,778 | -6.6% | 0.07% | -26.5% |
Q3 2016 | $6,252,000 | +8.4% | 190,261 | -0.4% | 0.10% | +4.3% |
Q2 2016 | $5,769,000 | +165.2% | 191,104 | +147.4% | 0.09% | +154.1% |
Q1 2016 | $2,175,000 | -69.0% | 77,231 | -62.6% | 0.04% | -72.6% |
Q4 2015 | $7,010,000 | +6.6% | 206,485 | -0.1% | 0.14% | +8.0% |
Q3 2015 | $6,575,000 | +0.1% | 206,630 | +100.3% | 0.12% | +12.6% |
Q2 2015 | $6,571,000 | +27.7% | 103,136 | +37.1% | 0.11% | +26.1% |
Q1 2015 | $5,146,000 | -6.4% | 75,206 | -3.7% | 0.09% | 0.0% |
Q4 2014 | $5,497,000 | -3.8% | 78,098 | -2.4% | 0.09% | +2.3% |
Q3 2014 | $5,715,000 | -0.7% | 79,998 | +3.3% | 0.09% | +3.6% |
Q2 2014 | $5,753,000 | +0.4% | 77,425 | -12.4% | 0.08% | -6.7% |
Q1 2014 | $5,732,000 | +12.2% | 88,353 | +2.6% | 0.09% | +9.9% |
Q4 2013 | $5,111,000 | +101.5% | 86,092 | +76.3% | 0.08% | +97.6% |
Q3 2013 | $2,536,000 | +14.2% | 48,832 | +4.0% | 0.04% | +5.1% |
Q2 2013 | $2,221,000 | – | 46,965 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |